A Feasibility Trial to Investigate the Safety and Between-group Effect Size of Stimulan-VG and Standard of Care (SoC) in Participants With Diabetic Foot Osteomyelitis of the Forefoot.

Condition:   Diabetic Foot Osteomyelitis Interventions:   Drug: Stimulan-VG;   Drug: Systemic Antibiotics Sponsors:   Biocomposites Ltd;   Parexel Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials